
<p>The way life sciences companies have commercialised products for years is being challenged from every direction. Changing customer expectations, growing market complexity, new technologies, and evolving healthcare...


science
Hosted by Improzo · science · EN
You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
29%
Guest openness
Selective
Sign up to generate a grounded pitch for Improzone.
Signup to Generate a PitchYou’re about to enter a new dimension, where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.
Improzone is hosted by Improzo. The show has published 15 episodes to date.
Recent episodes include "Season 2 Episode 5.2 The Future of Commercialization Is Closer Than You Think" (20 August 2026, 41 minutes), "Season 2 Episode 5.1 The Build vs. Buy Question: Workforce, AI, and the New Rules of Commercialization" (22 July 2026, 38 minutes), and "Season 2 Episode 4.3 CRM Reimagined: The Future of CRM in Life Sciences" (24 June 2026, 25 minutes).
Improzone publishes roughly monthly, with episodes averaging 30 minutes across 15 episodes.
Booking probability for Improzone is 29%, and the host is rated Selective on guests. Improzone requires a Pod Score of 80 or higher. Improzone's contact route on record: verified email.
The strongest fits for Improzone are Scientific Research & Development and IT Services & Software Development. Improzone has a science audience.
Improzo hosts Improzone, a science podcast with 15 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

<p>The way life sciences companies have commercialised products for years is being challenged from every direction. Changing customer expectations, growing market complexity, new technologies, and evolving healthcare...

<p>AI is changing the way life sciences organisations think about technology, talent, and transformation. But as the pace of innovation accelerates, one question is becoming harder to ignore:</p><p>What should companies...

<p>Season 2 Miniseries Episode 4.3 is officially live.</p><p>New Improzone Podcast Episode </p><p>In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to...

<p>Season 2 Miniseries Episode 4.2 is officially live.New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the...

Episode #4
<p>Season 2 Episode 4.1 is officially live.</p><p><br></p><p>New Improzone Podcast Episode</p><p>In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore...

<p>New Improzone Podcast Episode</p><p>Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond...

<p>New Improzone Podcast Episode</p><p>Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale.Key takeaways:•...

<p>Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental...

<p>We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive...

<p>In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented...

<p>In Part 2 of The AI Adoption Arc, we break down the critical shift to building proprietary LLM agents. Discover the severe security vulnerabilities introduced by prompt injection and data contamination in custom...

Episode #4
<p>How do life sciences organizations move from AI buzzwords to business impact?</p><p>In this episode of The Improzone, discover how to start small, build trust, and make AI your co-pilot for smarter pharma...

<p>Here comes our 3rd podcast of the ImproZone!</p><p>Join host Jane Urban and Indy Sawhney (AWS) as this episode speaks directly on the execution of Generative AI in Life Sciences.</p><p>We dive into how #GenerativeAI...

<p>New Podcast Episode of The Improzone! </p><p>Can AI and privacy coexist in pharma? In this episode, our host Jane Urban talks to Improzo's Abhishek Trigunait and Enkrypt AI's Nathan Trueblood about making responsible...

<p>You’re about to enter a new dimension—where AI doesn’t just sit in dashboards, it makes decisions.</p><p>Improzo CEO Inderpreet Kambo joins host Jane Urban to talk about building modular, pharma-native AI agents that...
Recent guests on Improzone. Study who booked and why before you pitch.
Guidehouse
PitchCentric classifies Improzone under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ